Identification of a BRCA2 mutation in a Turkish family with early‐onset breast cancer

We used a multi‐gene panel testing to identify the germline variants in a mother‐daughter pair with early‐onset breast cancer, and detected one pathogenic protein‐truncating variant in BRCA2. Our results highlight the importance of genetic testing in identifying the pathogenic mutation running in cancer families.

• Publication year

  2018

• Venue

  Clinical Case Reports

• Publication date

  2018-07-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccr3.1625PMID 30214756PMCID 6132100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of a BRCA2 mutation in a Turkish family with early‐onset breast cancer

  2018cited by this paper
• Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma

  2017cited by this paper
• Integrating personalized genomics into Turkish healthcare system: A cancer-oriented pilot activity of Istanbul Northern Anatolian Public Hospitals with GLAB

  2017cited by this paper
• The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance

  2016cited by this paper
• Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes.

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels

  2015cited by this paper
• The ATM signaling network in development and disease

  2013cited by this paper
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• MutationTaster evaluates disease-causing potential of sequence alterations

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer

  2008cited by this paper
• The FATC Domains of PIKK Proteins Are Functionally Equivalent and Participate in the Tip60-dependent Activation of DNA-PKcs and ATM*

  2006cited by this paper
• The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

  2006cited by this paper
• DSS1 is required for the stability of BRCA2

  2006cited by this paper
• Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene?

  2006cited by this paper
• The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction

  2005cited by this paper
• BRCA1 and BRCA2 sequence variants in Chinese breast cancer families

  2002cited by this paper
• Nuclear localization signals of the BRCA2 protein.

  2000cited by this paper

• MICA‐129 Met/Val polymorphism could be a genetic biomarker for Familial Breast Cancer in the Tunisian population

  2020cites this paper
• Identification of a BRCA2 mutation in a Turkish family with early‐onset breast cancer

  2018cites this paper